You may have heard about Moderna, Inc. by now. The biotech company has been making waves in the news lately with its cutting-edge, potentially life-saving research. To date, they’ve raised over $2 billion in venture capital and are valued at over $7 billion. That’s a lot of money, and it’s no wonder why so many people are curious about Moderna.
Where is Moderna, Inc. headquarters located?
Their headquarters is in 200 Technology Square, Cambridge, MA 02139, United States. The company occupies a total of 191,000 square feet of office space in the city, spread across two buildings.
You can reach them at +1 617 714 6500 or toll-free at (888) 986-8036. They’re open from 8 am to 5 pm EST.
Where Is the Moderna, Inc. Corporate Office Headquarters?
The company was founded in 2010 by Stacey J. Nobel and Derrick J. Rossi and has since become a leading developer of messenger RNA (mRNA) therapeutics.
Today, Moderna, Inc. boasts a team of over 1,000 employees and has developed 19 mRNA products that are currently in various stages of development. The company’s corporate office is located in Cambridge, Massachusetts, and it also has offices in Kendall Square, Boston; Houston, Texas; Vienna, Austria; and Zug, Switzerland.
How do I contact Moderna, Inc.’s corporate office?
If you are looking to contact Moderna corporate office, you can easily do so by email or phone.
Email: [email protected]
Phone: +1 617 714 6500
Moderna Short History
Moderna, Inc. is a renowned biotechnology company that was founded in 2009 by Noubar Afeyan, Robert S. Langer, Derrick Rossi, and Kenneth R. Chien. Moderna company is headquartered in Cambridge, Massachusetts, and specializes in the development of mRNA-based drugs.
In its early years, Moderna was met with a fair amount of skepticism from the scientific community. However, Moderna company has since gone on to become one of the most successful and well-funded biotechnology firms in the world. In fact, Moderna is now valued at more than $7 billion USD.
Moderna is a therapeutics company that specializes in the development of messenger RNA (mRNA) based therapeutics and vaccines. Moderna’s mRNA platform is based on technology licensed from the Massachusetts Institute of Technology (MIT), the Harvard School of Medicine, and the Boston Children’s Hospital.
Moderna’s mission is to harness the power of RNA to deliver on the promise of precision medicine. The company is advancing a new class of therapeutics and vaccines by translating the fundamentals of RNA science into breakthrough innovations that treat and protect people of all ages.
Moderna is a pioneer in the area of mRNA therapeutics and vaccines. The company’s mRNA platform has the potential to create a new class of highly effective and safe medicines and vaccines for a wide range of diseases and conditions.
Moderna’s mRNA platform is based on cutting-edge science that is revolutionizing the way we think about and treat disease.
Moderna, Inc. CEO and key executive team
|Noubar Afeyan||Co-founder and Chairman|
|Stephane Bancel||Chief Executive Officer, Board Member|
|Juan Andres||Chief Technical Operations and Quality Officer|
|Tracey Franklin||Chief Human Resources Officer|
|Source: modernatx.com, modernatx.com|
What Are Moderna’s Products and services?
As a top-leading company in the field of biotechnology, Moderna, Inc. is primarily concerned with the research and production of ground-breaking pharmaceuticals and vaccines. Moderna is in an excellent position to make a substantial contribution to the area of medicine as a result of the robust pipeline of drugs that are currently under development.
The city of Cambridge, in the state of Massachusetts, is home to the headquarters of Moderna, which was established in 2010. The history of invention at this firm is broad, and it has been recognized with a great number of patents in recognition of the important contributions it has made to the area of biotechnology.
In addition to being a biotechnology firm, Moderna, Inc. is primarily concerned with the research and development of messenger RNA (mRNA) treatments. mRNA is a kind of genetic material that may be used to direct the production of proteins in cellular organisms.
The development of therapies for health problems such as cancer, infectious diseases, cardiovascular disorders, and uncommon genetic diseases is one of the company’s offerings, along with other goods and services. In addition, Moderna provides services for the discovery of new drugs. These services include the identification of potential drug targets, the creation of new tests, and medicinal chemistry.
What are Companies Owned by Moderna, Inc.?
Moderna, Inc. is a biotechnology company with a focus on developing vaccines and gene therapies. The company was founded in 2009 by current CEO Stephane Bancel.
Moderna is headquartered in Cambridge, Massachusetts, and has offices all over the world. As of December 2017, the company had total cash and cash equivalents of $1.5 billion.
One of Moderna’s most well-known products is the mTA vaccine, which is used to prevent tuberculosis. The company has also developed vaccines for Zika, herpes, and human papillomavirus (HPV).
Why Moderna Looks Better Than Pfizer as a Long-Term Buy?
Moderna and Pfizer are two of the well-known promising vaccine candidates in the race to develop a COVID-19 vaccine. Both companies have released Phase III trial data that shows their vaccines are highly effective at preventing the disease. So which company looks better as a long-term investment?
Moderna looks better than Pfizer as a long-term investment for several reasons. First, Moderna’s vaccine is more effective than Pfizer’s. Moderna’s vaccine is also easier to store and transport, which will make it easier to distribute once it is approved. Moderna’s mRNA-based vaccine candidate appears to be more effective than Pfizer’s, and it also has certain logistical advantages.
Moderna’s vaccine can be stored at regular refrigerator temperatures for 30 days, while Pfizer’s must be stored at ultra-cold temperatures. Moderna is also ramping up production more quickly than Pfizer.
Finally, Moderna has a stronger patent portfolio than Pfizer, which will help the company protect its market share in the years to come.
You may have heard about Moderna, Inc. lately because of their groundbreaking work in the field of gene therapy. But what is Moderna, Inc. exactly? And what do they do?
Moderana, Inc. is a leading biotech company that focuses on the development of new drugs and vaccines. They were founded in 2011, and since then, they’ve raised over $2 billion in funding and launched over 20 products.
Their work in gene therapy is particularly groundbreaking. They’re the first company to develop a drug that can be used to treat multiple diseases by editing a patient’s genes. This could potentially revolutionize the way we treat diseases like cancer, heart disease, and Alzheimer’s.